Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia
Ioannis Liampas, Silvia Demiri, Vasileios Siokas, Antonia Tsika, Chrysa Marogianni, Polyxeni Stamati, Grigorios Nasios, Lambros Messinis et al.. International journal of molecular sciences, 2025-09-03
Topic: Genetics and APOE
Plain-language summary
We investigated associations between apolipoprotein E (APOE) alleles and motor manifestations in Alzheimer's dementia (AD) capitalizing on National Alzheimer's Coordinating Center data: the baseline evaluations of older adults (≥60 years) with a diagnosis of AD were analyzed. Those with a concomitant diagnosis Parkinson's disease or other parkinsonian syndrome, and those treated with anti-parkinsonian agents were excluded. Three APOE groups were formed: APOE2 (APOE2 carriers), APOE3 (APOE3/APOE3) and APOE4 (APOE4/APOE4, APOE4/APOE3). UPDRS-III was used to assess the presence or absence of motor signs in 9 domains. Adjusted binary logistic models featuring the three APOE groups as exposures and motor domains as outcomes were estimated. There were 389 individuals in the APOE2, 1799 in the APOE3 and 2791 in the APOE4 groups. Compared to the APOE2 group, individuals in the APOE4 group had lower odds of having at least one motor sign [0.64 (0.50-0.82)]. Among motor signs, rigidity [0.53 (0.34-0.81)], bradykinesia [0.56 (0.40-0.77)], impaired chair rise [0.54 (0.37-0.78)] and impaired posture-gait [0.54 (0.36, 0.81)] exhibited significant associations. Exploratory analyses featuring APOE genotypes suggested dose-response relationships for both APOE2 and APOE4. In conclusion, APOE2 confers a risk towards motor (mainly parkinsonian) signs in AD. APOE4 may have a protective effect.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Liampas, I., Demiri, S., Siokas, V., Tsika, A., Marogianni, C., Stamati, P., et al. (2025). Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia. International journal of molecular sciences. https://doi.org/10.3390/ijms26178562
Vancouver
Liampas I, Demiri S, Siokas V, Tsika A, Marogianni C, Stamati P, et al. Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia. International journal of molecular sciences. 2025. doi:10.3390/ijms26178562. PMID: 40943487.
BibTeX
@article{liampas2025-40943487,
author = {Liampas, Ioannis and Demiri, Silvia and Siokas, Vasileios and Tsika, Antonia and Marogianni, Chrysa and Stamati, Polyxeni and Nasios, Grigorios and Messinis, Lambros and others},
title = {{Apolipoprotein E Alleles and Motor Signs in Older Adults with Alzheimer's Dementia}},
journal = {International journal of molecular sciences},
year = {2025},
doi = {10.3390/ijms26178562},
pmid = {40943487},
url = {https://doi.org/10.3390/ijms26178562}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Compared to the APOE2 group, individuals in the APOE4 group had lower odds of having at least one motor sign [0.64 (0.50-0.82)].
- Among motor signs, rigidity [0.53 (0.34-0.81)], bradykinesia [0.56 (0.40-0.77)], impaired chair rise [0.54 (0.37-0.78)] and impaired posture-gait [0.54 (0.36, 0.81)] exhibited significant associations.
- In conclusion, APOE2 confers a risk towards motor (mainly parkinsonian) signs in AD.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants389
- Evidence strengthLow
How this study scored 52/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 29 of the 56 points we could judge it on, which is 52 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International journal of molecular sciences) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 389 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40943487) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 29 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 29 of the 56 points we could judge it on is 52 out of 100. |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “apoe2”
265 studies in the library carry the topic tag “apoe2”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 265 tagged studies.